EUVIMEDEUVIMED entdecken
Crossref

Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry

Kannu Bansal iD, Aakriti Soni, Miloni Shah, Andrzej S Kosinski iD, Fahad Gilani, Sahil Khera iD, Sreekanth Vemulapalli iD, Sammy Elmariah iD, Dhaval Kolte iD

Circulation: Cardiovascular Interventions · 2023

DOI: 10.1161/circinterventions.123.013578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023. Verfasst von Kannu Bansal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA (K.B., A.S.). Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Ischemic Attack, Transient, Aortic Valve Stenosis, Stroke. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atherosclerotic cardiovascular disease is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Polyvascular disease (PVD), defined as involvement of ≥2 vascular beds (VBs), that is, coronary, cerebrovascular, or peripheral, portends a poor prognosis in patients with atherosclerotic cardiovascular disease; however, data on the association of PVD with outcomes of patients undergoing TAVR are limited. METHODS: The Society of Thoracic Surgeons and the American College of Cardiology Transcatheter Valve Therapy Registry was analyzed to identify patients who underwent TAVR from November 2011 to March 2022. The exposure of interest was PVD. The primary outcome was all-cause mortality. Secondary outcomes included major vascular complications, major/life-threatening bleeding, myocardial infarction, transient ischemic attack/stroke, and valve- and non–valve-related readmissions. Outcomes were assessed at 30 days and 1 year. RESULTS: Of 443 790 patients who underwent TAVR, PVD was present in 150 823 (34.0%; 111 425 [25.1%] with 2VB-PVD and 39 398 [8.9%] with 3VB-PVD). On multivariable analysis, PVD was associated with increased all-cause mortality at 1 year (hazard ratio, 1.17 [95% CI, 1.14–1.20]). There was an incremental increase in 1-year mortality with an increasing number of VBs involved (no PVD [reference]; 2VB-PVD: hazard ratio, 1.12 [95% CI, 1.09–1.15]: and 3VB-PVD: hazard ratio, 1.31 [95% CI, 1.26–1.36]). Patients with versus without PVD had higher rates of major vascular complications, major/life-threatening bleeding, transient ischemic attack/stroke, and non–valve-related readmissions at 30 days and 1 year. CONCLUSIONS: PVD is associated with worse outcomes after TAVR, and the risk is highest in patients with 3VB-PVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementIschemic Attack, TransientAortic Valve StenosisStrokeHumansUnited StatesTreatment OutcomeRegistriesAortic ValveRisk Factors

Stichwörter der Autor:innen

aortic valve stenosisatherosclerosismortalityregistriestranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA (K.B., A.S.).
  • Duke Clinical Research Institute, Durham, NC (M.S., A.S.K.).
  • Division of Cardiovascular Medicine, Catholic Medical Center, Manchester, NH (F.G.).
  • Division of Interventional Cardiology, Mount Sinai Hospital, New York, NY (S.K.).
  • Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC (S.V.).
  • Division of Cardiology, Duke University Medical Center, Durham, NC (S.V.).

ORCID-Profile: Kannu Bansal, Andrzej S Kosinski, Sahil Khera, Sreekanth Vemulapalli, Sammy Elmariah, Dhaval Kolte

Zitieren

APA

Bansal, K., Soni, A., Shah, M., Kosinski, A. S., Gilani, F., Khera, S., Vemulapalli, S., Elmariah, S., & Kolte, D. (2023). Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013578

Vancouver

Bansal K, Soni A, Shah M, Kosinski AS, Gilani F, Khera S, et al. Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry. Circulation: Cardiovascular Interventions. 2023. doi:10.1161/circinterventions.123.013578

BibTeX
@article{Bansal2023,
  author = {Bansal, Kannu and Soni, Aakriti and Shah, Miloni and Kosinski, Andrzej S and Gilani, Fahad and Khera, Sahil and Vemulapalli, Sreekanth and Elmariah, Sammy and Kolte, Dhaval},
  title = {Association Between Polyvascular Disease and Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2023},
  doi = {10.1161/circinterventions.123.013578}
}
Kostenlos starten →